A lab-made four-part skin peptide modeled on a youth signal from the thymus gland, sold to firm aging skin. Its firming actions are biologically plausible and confirmed in lab-grown cells, but human proof is thin and mostly company-generated, and whether it passes the skin barrier is unclear. A low-risk, lightly-evidenced add-on. (Full Review)

Protocol

Form & Concentration

Serum or cream

Favor products where the peptide appears high on the ingredient list, not at the very end.

Frequency

Twice daily

Morning and evening for about eight weeks; consistency over weeks matters more than any single application.

Layering

Apply to clean skin first

Apply before heavier creams and oils and let it absorb before layering occlusive products.

Time to effect

Visible Firmness

4–8 weeks

Firmness changes, if they occur, require consistent twice-daily use; there is no immediate effect.

Benefits

Medium: Increased skin firmness

Low: Improved skin mechanical resilience; support for collagen and cell-matrix cohesion

Speculative: Local immune and barrier signaling

Contraindications

Known allergy to the product or its components

Pregnancy or breastfeeding (precautionary; no pregnancy-specific safety data)

Key Interactions

Co-applied topical prescriptions (tretinoin, topical corticosteroids)

Co-applied OTC exfoliating acids (glycolic acid, salicylic acid), benzoyl peroxide

Layered retinoids or vitamin C

Procedural treatments (microneedling, peels, laser)

Risk & Side Effects

Low: Local skin irritation and sensitivity; allergic contact dermatitis

Speculative: Theoretical immune-signaling effects

Monitoring

Marker	Target	Why
Vitamin D, 25-OH	40–60 ng/mL	Supports skin and immune health within a longevity program
Vitamin C (plasma ascorbate)	0.8–1.4 mg/dL	Cofactor for collagen synthesis, the same pathway firming claims target
hs-CRP	< 1.0 mg/L	Low-grade inflammation can accelerate visible skin aging

Cadence: Optional general-health markers every 6–12 months; visual firmness reviewed at baseline, 4 weeks, and 8–12 weeks, then every 3–6 months.

Qualitative Assessment

Visible firmness and skin tightness of the treated area, judged against baseline photographs
Skin smoothness, fine-line appearance, and overall radiance
Local tolerance: presence or absence of redness, stinging, dryness, or itching
Subjective satisfaction and whether results justify continued use and cost

Acetyl Tetrapeptide-2 for Skin Rejuvenation

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment